Search the Newsreel

UBS Group Boosts Elanco Animal Health (NYSE:ELAN) Price Target to $33.00

Elanco Animal Health (ELAN) Stock Eyes Margin Momentum As Debt Questions Linger

Elanco Animal Health's stock rose 2.4% following its Q2 2026 report, which showed significant improvement in adjusted EBITDA and gross margin, despite trailing losses. The company's "Big 6" portfolio and new products like Zenrelia and Credelio Quattro are driving revenue growth and market penetration. …

Elanco Animal Health posts Q2 2026 revenue $1.37B, raises full‑year guidance and improves net leverage

Elanco Animal Health reported strong second-quarter 2026 results, achieving $1.368 billion in revenue, a 10% year-over-year increase, and raising its full-year guidance for revenue, adjusted EBITDA, and adjusted EPS. The company also improved its year-end net leverage target and saw significant contributions from products …

CELANESE CORP : BAIRD CUTS TARGET PRICE TO $65 FROM $75

Baird has reduced its target price for Celanese Corp (CE.N) shares from $75 to $65. This news was reported by Reuters on August 6, 2026. The article itself is a brief announcement without further details or analysis.

Elanco Earnings: Continued Strength in Key New Products Supports Strong Quarter

Celanese Corp (CE) (Q2 2026) Earnings Call Highlights: Strategic Agility and Growth Amid Market ...

This article first appeared on GuruFocus. Release Date: August 05, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Celanese Corp (NYSE:CE) demonstrated strong operational agility by restarting the Frankfurt plant in about 5 …

Elanco Animal Health Inc (ELAN) (Q2 2026) Earnings Call Highlights: Strong Innovation Drives 8% ...

This article first appeared on GuruFocus. Revenue: $1.368 billion, up 10% reported; organic constant currency revenue grew 8%. Organic Growth Drivers: 6% increase in volume and 2% contribution from price. Pet Health Revenue (Organic CC): Total grew 11%; US up 11%, International up 9%. …

LAKELAND FINANCIAL CORP Q2 2026: Net income $28.44M, EPS $1.13— 10-Q Summary

LAKELAND FINANCIAL CORP reported its second-quarter 2026 results with a net income of $28.44 million, an increase from $26.97 million in the prior year, and diluted EPS of $1.13, up from $1.04. The company saw growth across core revenue streams, including net interest income …

Elanco Animal Health (NYSE:ELAN) Hits New 1-Year High Following Strong Earnings

Elanco Animal Health (NYSE:ELAN) shares reached a new 52-week high after reporting strong quarterly earnings of $0.34 EPS, surpassing estimates, with revenue rising 10.2% to $1.37 billion. The company provided Q3 and full-year 2026 EPS guidance, and analysts maintain a "Moderate Buy" rating with …

Informe de resultados de Celanese: supera el BPA del Q2 2026, pero las acciones caen un 7%

Press Release: Elanco Animal Health Reports Second Quarter 2026 Results

Elanco Animal Health (ELAN) has reported its second-quarter 2026 results. The article also briefly mentions Unity Software (U.US) which reported fourth-quarter revenue of $609 million, exceeding estimates, despite a quarterly loss of 66 cents per share. Full details of the Elanco report are behind …

Celanese Q2 Earnings Beat Estimates on Pricing and Execution

Celanese Corporation CE reported second-quarter 2026 adjusted earnings of $2.45 per share, up 71.3% from $1.43 a year ago. The bottom line surpassed the Zacks Consensus Estimate of $2.21 by 10.9%. Net sales rose 8.7% year over year to $2.75 billion and beat the …

Lakeland Fire + Safety Announces UL Certification of Veridian Wildland Glove to NFPA 1950 Standard

Lakeland Fire + Safety (NASDAQ: LAKE) announced that its Veridian Wildland Glove has received UL certification to NFPA 1950 (1977), 2025 edition, expanding its protective glove offering for wildland and urban interface firefighters. This certification confirms the glove meets the relevant NFPA standard for …

Elanco Animal Health (ELAN) Reports Q2 Earnings: What Key Metrics Have to Say

Elanco Animal Health Incorporated (ELAN) reported $1.37 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 10.2%. EPS of $0.34 for the same period compares to $0.26 a year ago. The reported revenue compares to the Zacks Consensus Estimate …

Celanese Corporation Q2 2026 Earnings Call Summary

Celanese Corporation Q2 2026 Earnings Call Summary - Moby Strategic Execution and Market Dynamics Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. …

Lakeland Plans Rollout of Certified Glove for Wildland Firefighters

Lakeland Fire + Safety (NASDAQ: LAKE) announced that its Veridian Wildland Glove has received UL certification to the NFPA 1950 (1977), 2025 edition standard for wildland and urban interface firefighting. This certification expands Lakeland's portfolio of certified firefighter protective equipment. The company plans a …

(ELAN) Elanco Animal Health Expects 2026 Revenue Range $5.09B - $5.14B, vs. FactSet Est of $5.07B

Elanco Animal Health (ELAN) announced its revenue expectations for 2026, forecasting a range of $5.09 billion to $5.14 billion. This projection surpasses the current FactSet estimate of $5.07 billion. The company also reported Q2 adjusted earnings and revenue increases, leading to an updated 2026 …

(ELAN) Elanco Animal Health Incorporated Expects Q3 Revenue Range $1.20B - $1.22B

Elanco Animal Health Incorporated (ELAN) announced its Q3 revenue expectations, projecting a range of $1.20 billion to $1.22 billion. This follows their Q2 adjusted earnings and revenue rise, which led to an increase in their 2026 outlook, with revenue expected between $5.09 billion and …

Elanco Q2 2026 earnings: Innovation demand lifts revenue and margins

Elanco Animal Health reported strong Q2 2026 earnings, with revenue up 10% to $1.368 billion and GAAP EPS rising significantly due to demand for innovative pet health products and global ruminant portfolio growth. The company raised its full-year guidance for revenue, adjusted EBITDA, and …

Elanco’s (NYSE:ELAN) Q2 CY2026: Strong Sales, Stock Soars

Elanco (NYSE: ELAN) reported stronger-than-expected Q2 CY2026 results, with revenue of $1.37 billion, a 10.2% year-on-year increase, and non-GAAP EPS of $0.34, significantly beating analyst estimates. The animal health company also raised its full-year revenue and adjusted EPS guidance, indicating positive momentum in the …

Elanco raises 2026 outlook after Q2 revenue climbs 10%

Elanco Animal Health (ELAN) reported strong Q2 2026 results with revenue up 10% year over year to $1.368 billion, and net income rising significantly. Following this performance, the company has raised its full-year 2026 financial outlook, including revenue and adjusted EPS guidance, and increased …

Elanco beats top-line and bottom-line estimates; raises FY26 outlook

* Elanco press release [https://seekingalpha.com/pr/20607348-elanco-animal-health-reports-second-quarter-2026-results] (ELAN [https://seekingalpha.com/symbol/ELAN]): Q2 Non-GAAP EPS of $0.34 beats by $0.07. * Revenue of $1.37B (+10.5% Y/Y) beats by $60M. * Adjusted EBITDA of $288 million; Adjusted EBITDA Margin of 21.2% * Full Year 2026 Guidance: * Raising innovation revenue …

Elanco Animal Health Incorporated (ELAN) Q2 Earnings and Revenues Beat Estimates

Elanco Animal Health (ELAN) reported strong Q2 2026 earnings, beating analyst estimates for both EPS and revenue. The company posted earnings of $0.34 per share against an estimate of $0.27, and revenues of $1.37 billion, surpassing the $1.24 billion expectation. Despite this positive performance, …

Lakeland Financial (Nasdaq: LKFN) posts Q2 2026 profit and loan growth

Celanese (CE) Stock Price Drops As Revenue Recovery Meets Profit Compression

Celanese Corporation 2026 Q2 - Results - Earnings Call Presentation (NYSE:CE) 2026-08-05

Celanese Corporation Q2 2026 Earnings Call Summary - Moby Strategic Execution and Market Dynamics Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. …

Elanco Animal Health Incorporated 2026 Q2 - Results - Earnings Call Presentation (NYSE:ELAN) 2026-08-05

Elanco Animal Health reported strong second-quarter 2026 results, exceeding prior guidance with revenue up 10% to $1.368 billion, driven by new pet-health products like Zenrelia and Credelio Quattro, and growth in U.S. farm animal operations. The company raised its full-year organic constant-currency revenue growth …

Resultados de Celanese: ¿Defenderá la directiva sus previsiones?

Celanese (NYSE:CE) Issues Q3 2026 Earnings Guidance

Celanese (NYSE:CE) Announces Quarterly Earnings Results

Compared to Estimates, Celanese (CE) Q2 Earnings: A Look at Key Metrics

For the quarter ended June 2026, Celanese (CE) reported revenue of $2.75 billion, up 8.7% over the same period last year. EPS came in at $2.45, compared to $1.44 in the year-ago quarter. The reported revenue represents a surprise of +3.69% over the Zacks …

Celanese (CE) Tops Q2 Earnings and Revenue Estimates

Celanese (CE) came out with quarterly earnings of $2.45 per share, beating the Zacks Consensus Estimate of $2.21 per share. This compares to earnings of $1.44 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings …

Celanese Q2 Profit Down

(RTTNews) - Celanese Corp. (CE) on Tuesday reported a drop in profit for the second quarter. The chemical and specialty materials company reported second-quarter net earnings of $125 million, or $1.13 per share, compared with $197 million, or $1.80 per share, in the prior-year …

Lakeland Industries | 4: Statement of changes in beneficial ownership of securities-Officer Yartz Laurel A.

This document is a Statement of Changes in Beneficial Ownership of Securities (Form 4) for Laurel A. Yartz, an officer of Lakeland Industries. It records modifications in her holdings of the company's securities, as required by the SEC.

Celanese Corporation Reports Second Quarter Earnings

DALLAS, August 04, 2026--(BUSINESS WIRE)--Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today reported second quarter 2026 U.S. GAAP diluted earnings per share of $1.15 and adjusted earnings per share of $2.45. Net sales of $2.8 billion increased 18 percent sequentially, …

Celanese Corp. stock outperforms competitors on strong trading day

Celanese Corp. (CE) shares rose 3.08% to $45.24 on Tuesday, outperforming the broader market indices like the S&P 500 and Dow Jones Industrial Average. This gain ended a two-day losing streak for the company's stock. The overall stock market experienced a strong trading session, …